Carmen J. Allegra

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Eric Van Cutsem, Josep Tabernero, Radek Lakomý et al. · Journal of Clinical Oncology · 2012 · 1.4K citations

Medicine, Oncology, Pharmacology +15

Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03

Mark S. Roh, Linda H. Colangelo, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2009 · 942 citations · Full text

Medicine, Oncology, Surgery +17

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

Greg Yothers, Michael J. O’Connell, Carmen J. Allegra et al. · Journal of Clinical Oncology · 2011 · 662 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

Carmen J. Allegra, Greg Yothers, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2010 · 594 citations

Medicine, Oncology, Pharmacotherapy +16

DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

Frank A. Sinicrope, Nathan R. Foster, Stephen N. Thibodeau et al. · JNCI Journal of the National Cancer Institute · 2011 · 529 citations

Medicine, Molecular Biology, Oncology +17